An advanced wound dressing combining the antimicrobial peptide LL37 in microspheres with activated carbon-chitosan hydrogel killed multiple bacterial species, neutralized bacterial toxins, and promoted cell migration without toxicity.
3 pathogens killedThe LL37-AC-CS hydrogel was effective against E. coli, P. aeruginosa, and S. aureus — three bacteria commonly responsible for chronic wound infections
What the researchers found
The LL37-activated carbon-chitosan (LL37-AC-CS) hydrogel demonstrated effectiveness against three clinically important bacteria: Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. The hydrogel bound more endotoxin than activated carbon with chitosan hydrogel alone, indicating synergistic toxin-neutralizing capacity. The dressing induced cell migration after 72 hours (promoting wound closure) and showed no cytotoxicity toward normal human dermal fibroblasts (NHDF) after 72 hours of treatment.
The microsphere encapsulation strategy successfully protected LL37 from degradation in wound fluid, maintaining its antimicrobial activity in an environment where the free peptide would normally lose effectiveness.
Why it matters
Chronic wound infections are a major healthcare burden, and antibiotic resistance is making them harder to treat. LL37 has no known bacterial resistance, making it an attractive alternative, but it degrades quickly in wound environments. This delivery system solves that problem while adding toxin-neutralizing capability — addressing both the bacteria and the harmful substances they release when they die.
How the study worked
LL37 was encapsulated in microspheres, which were loaded onto an activated carbon-chitosan hydrogel. The formulation was characterized for physicochemical properties, drug release kinetics, and peptide-polymer compatibility. Antimicrobial activity was tested against E. coli, P. aeruginosa, and S. aureus. Antibiofilm activity, endotoxin binding capacity, cell migration assays, and cytotoxicity testing with normal human dermal fibroblasts were performed.
What this study cannot tell us
This was entirely an in vitro study — no animal or human wound healing trials were conducted. The activated carbon component's long-term effects in wounds are unknown. The study did not assess performance in actual wound fluid or against polymicrobial biofilms typical of chronic wounds. Manufacturing scalability and cost were not addressed.
How to read the evidence
This is a preclinical in vitro study demonstrating proof-of-concept for a novel peptide delivery system. While the results across multiple assays (antimicrobial, antitoxin, cell migration, cytotoxicity) are comprehensive, no in vivo validation has been performed.
When this study was published
Published in 2024, this is recent research in the active field of antimicrobial peptide wound dressings, where several formulations are in various stages of development.
The bigger picture
This study exemplifies the growing field of antimicrobial peptide therapeutics, where the challenge is less about the peptide's efficacy and more about delivering it effectively. The microsphere-hydrogel platform could serve as a model for delivering other fragile antimicrobial peptides, and the dual antibacterial-antitoxin approach addresses a gap in current wound care where bacterial lysis products can paradoxically worsen inflammation.
Questions still open
- How does the LL37-AC-CS hydrogel perform in animal wound models with established chronic infections?
- Could this microsphere delivery approach be adapted for other antimicrobial peptides that face similar degradation challenges?
- How does the cost and manufacturing complexity compare to conventional antimicrobial wound dressings?
Common questions
What is LL37 and why is it special?
Why does the dressing also need to neutralize bacterial toxins?
Read the original research
LL37 Microspheres Loaded on Activated Carbon-chitosan Hydrogel: Anti-bacterial and Anti-toxin Wound Dressing for Chronic Wound Infections.
AAPS PharmSciTech, 25(5), 110
Citation
Lim, Bee-Yee; Azmi, Fazren; Ng, Shiow-Fern. (2024). LL37 Microspheres Loaded on Activated Carbon-chitosan Hydrogel: Anti-bacterial and Anti-toxin Wound Dressing for Chronic Wound Infections.. AAPS PharmSciTech, 25(5), 110. https://doi.org/10.1208/s12249-024-02826-6